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journa l homepage: www.e lsev ier .com/ locate / i j idUntil the late 1970s, seeing an end to infectious diseaseswas still
a commongoal amonghealthcareworkers, and the relative concepts
of infectious disease prevention, treatment, and care could be found
in the specialized literature and in medicine textbooks.1 The Italian
Severe Infections Study Group (Gruppo Italiano di Studio sulle
Infezioni Gravi – GISIG) project, involving a national group of Italian
experts in the ﬁeld of healthcare-associated infectious diseases, was
set up in the early 1990s and was rather innovative at this time, as
was their multidisciplinary approach. Specialists in clinical micro-
biology, epidemiology, critical care medicine, infectious diseases,
and surgerywere involved inall phasesof theproject. In theﬁrst two
GISIG editions, the objectives were to describe the epidemiology of
the severe healthcare-associated infectious diseases, the relevant
diagnostic procedures, and the most suitable antibiotic and non-
antibiotic therapeutic strategies for selected cases in medical and
critical care settings in Italy.2,3 All of the recommendations were
published in the Italian scientiﬁc literature and are available and
have been disseminated as pocket-sized handouts to interested
healthcare workers.
Ten years after the last consensus workshop and with an
expected generational change, in 2008 the GISIG project planned a
third phase, dedicated to the memory of two of its co-founders,
Pietro Martino and Francesco Di Raimondo. The aim of this
ambitious projectwas to identify themain controversial diagnostic
and therapeutic issues in each of the following severe healthcare-
associated infectious diseases: blood stream infections, health-
care-associated pneumonia, surgical site infections, orthopedic
infections, and central nervous system infections. The GISIG 3
project was characterized by an evidence-based rigorous meth-
odology centered on systematic research and quality evaluation of
the literature (based on the Newcastle–Ottawa scale and the
consolidated standards for reporting trials (CONSORT) method),
and on the deﬁnition of strength and level recommendations
(based on a modiﬁed Grade methodology). Five coordinators (one
from each working group) and two scientiﬁc secretaries took part
in two methodology seminars on the theoretical and practical
approaches to the research and literature quality evaluation,
conducted by an expert physician from the Cochrane collaboration.
An impressively large volume of studies, including randomized
clinical trials, longitudinal cohorts, comparative trials, case–
control studies, cases series, and single cases was assessed by
each working group; grateful thanks to each group member are
warranted. Recommendations based on expert opinion only were
strongly restricted. The consensus document of each working
group is presented and discussed in this supplement.1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
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Rome and for being co-editor of this supplement.
Finally, we hope that this ambitious evidence-based project can
be shared with the entire Italian healthcare worker community
and that the relative recommendations can be implemented in
everyday clinical practice, in order to continue to provide better
access to excellent healthcare for patients affected by severe
healthcare-associated infections.
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